ACAD9.md
... ...
@@ -22,7 +22,7 @@ timeline
22 22
23 23
|Entity|Tier|Description |
24 24
|:------:|:----:|--------------------------------------|
25
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
25
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
26 26
27 27
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
28 28
ACE.md
... ...
@@ -23,7 +23,7 @@ timeline
23 23
24 24
|Entity|Tier|Description |
25 25
|:------:|:----:|--------------------------------------|
26
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
26
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
27 27
28 28
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
29 29
ALPK2.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------------------|
22
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@paneaWholeGenomeLandscape2019]|
22
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@paneaWholeGenomeLandscape2019]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
CDH17.md
... ...
@@ -23,7 +23,7 @@ timeline
23 23
24 24
|Entity|Tier|Description |
25 25
|:------:|:----:|--------------------------------------|
26
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
26
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
27 27
28 28
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
29 29
CTCF.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
21 21
|Entity|Tier|Description |
22 22
|:------:|:----:|--------------------------------------|
23
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@paneaWholeGenomeLandscape2019]|
23
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@paneaWholeGenomeLandscape2019]|
24 24
25 25
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
26 26
CYP4F22.md
... ...
@@ -24,7 +24,7 @@ timeline
24 24
25 25
|Entity|Tier|Description |
26 26
|:------:|:----:|--------------------------------------|
27
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
27
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
28 28
29 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
30 30
DTX1.md
... ...
@@ -26,7 +26,7 @@ timeline
26 26
|:------:|:----:|--------------------------------------|
27 27
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@gomezUltraDeepSequencingReveals2023]|
28 28
|![MZL](images/icons/MZL_tier1.png)|1|high-confidence MZL gene[@rossiCodingGenomeSplenic2012c]|
29
-|![BL](images/icons/BL_tier2.png) |2-F | Failed QC[@loveGeneticLandscapeMutations2012]|
29
+|![BL](images/icons/BL_tier2.png) |3 | Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
30 30
|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@schmitzGeneticsPathogenesisDiffuse2018a]|
31 31
|![FL](images/icons/FL_tier1.png) |1-a | aSHM target and high-confidence FL gene |
32 32
FZD3.md
... ...
@@ -21,7 +21,7 @@ timeline
21 21
22 22
|Entity|Tier|Description |
23 23
|:------:|:----:|--------------------------------------|
24
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@paneaWholeGenomeLandscape2019]|
24
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@paneaWholeGenomeLandscape2019]|
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
27 27
GNAS.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|-----------------------------------------|
22
-|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC[@reddyGeneticFunctionalDrivers2017]|
22
+|![DLBCL](images/icons/DLBCL_tier2.png) |3 |Retired, Failed QC[@reddyGeneticFunctionalDrivers2017]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
MARK1.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
21 21
|Entity|Tier|Description |
22 22
|:------:|:----:|-----------------------------------------|
23
-|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC[@reddyGeneticFunctionalDrivers2017]|
23
+|![DLBCL](images/icons/DLBCL_tier2.png) |3 |Retired, Failed QC[@reddyGeneticFunctionalDrivers2017]|
24 24
25 25
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
26 26
POLRMT.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------------------|
22
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
22
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
PTPRK.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|-----------------------------------------|
22
-|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC[@reddyGeneticFunctionalDrivers2017]|
22
+|![DLBCL](images/icons/DLBCL_tier2.png) |3 |Retired, Failed QC[@reddyGeneticFunctionalDrivers2017]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
PTPRN.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------------------|
22
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
22
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
RARA.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|-----------------------------------------|
22
-|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
22
+|![DLBCL](images/icons/DLBCL_tier2.png) |3 |Retired, Failed QC|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
RBP3.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------------------|
22
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
22
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
RET.md
... ...
@@ -21,7 +21,7 @@ timeline
21 21
22 22
|Entity|Tier|Description |
23 23
|:------:|:----:|--------------------------------------|
24
-|![BL](images/icons/BL_tier2.png) |2-F |Failed QC[@loveGeneticLandscapeMutations2012]|
24
+|![BL](images/icons/BL_tier2.png) |3 |Retired, Failed QC[@loveGeneticLandscapeMutations2012]|
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
27 27